PMDA drug package insert
エルネオパNF1号輸液
PMDA Prescription drug · 株式会社大塚製薬工場 · package insert May 7, 2026
Key facts
| Brand names | エルネオパNF1号輸液, エルネオパNF2号輸液 |
|---|---|
| Nonproprietary names | アミノ酸・糖・電解質・ビタミン |
| Companies | 製造販売元／株式会社大塚製薬工場, 販売提携／大塚製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 高カロリー輸液用アミノ酸・糖・電解質・総合ビタミン・微量元素液 |
| Therapeutic category codes | 873259 |
| YJ codes | 3259533G1029, 3259533G2025, 3259533G3021, 3259534G1023, 3259534G2020, 3259534G3026 |
| Approval numbers | 22800AMX00422, 22800AMX00423 |
| Package insert edition | 第3版 |
| Package insert date | May 7, 2026 |
| PMDA document key | 180079_3259533G1029_1 |
| PMDA company code | 180079 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: